Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy
Frontiers in Bioscience-Landmark · 20.03.2025 · 30 (3)
DOI: 10.31083/fbl25203 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 20.03.2025. Verfasst von Juan F Santibanez. Beteiligte Einrichtung: Group for Molecular Oncology, Institute for Medical Research, National Institute of the Republic of Serbia, University of Belgrade, 11129 Belgrade, S…. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, Neoplasms, Immunotherapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myeloid-derived suppressor cells (MDSCs) are believed to be key promoters of tumor development and are recognized as a hallmark of cancer cells’ ability to evade the immune system evasion. MDSC levels often increase in peripheral blood and the tumor microenvironment (TME). These cells exert immunosuppressive functions, weakening the anticancer immune surveillance system, in part by repressing T-cell immunity. Moreover, MDSCs may promote tumor progression and interact with cancer cells, increasing MDSC expansion and favoring an immunotolerant TME. This review analyzes the primary roles of MDSCs in cancer and T-cell immunity, discusses the urgent need to develop effective MDSC-targeted therapies, and highlights the potential synergistic combination of MDSC targeting with chimeric antigen receptors and immune checkpoint inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Group for Molecular Oncology, Institute for Medical Research, National Institute of the Republic of Serbia, University of Belgrade, 11129 Belgrade, Serbia.
- Integrative Center for Biology and Applied Chemistry (CIBQA), Bernardo O'Higgins University, 8370993 Santiago, Chile.
Zitieren
APA
Santibanez, J. F. (2025). Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy. Frontiers in Bioscience-Landmark, 30(3). https://doi.org/10.31083/fbl25203
Vancouver
Santibanez JF. Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy. Frontiers in Bioscience-Landmark. 2025;30(3). doi:10.31083/fbl25203
BibTeX
@article{Santibanez2025,
author = {Santibanez, Juan F},
title = {Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
volume = {30},
number = {3},
doi = {10.31083/fbl25203}
}
EUVIMED